Literature DB >> 3043427

Ether lipids in the therapy of cancer.

R Andreesen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3043427

Source DB:  PubMed          Journal:  Prog Biochem Pharmacol        ISSN： 0079-6085


× No keyword cloud information.
  4 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11.

Authors:  J Kára; N I Zimakova; E A Serebryakova; V Dĕdková; A E Zolotaryov
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 3.  Inhibitors of phosphatidylinositol signalling as antiproliferative agents.

Authors:  G Powis; D Phil
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

Review 4.  Biotransformation of alkylglycerols in plant cell cultures: production of platelet activating factor and other biologically active ether lipids.

Authors:  H K Mangold; S S Apte; N Weber
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.